---
title: "Akebia Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/21584775-084d-4b62-a479-adba4c48a280
json: https://whiteintel.dev/api/public/dossier/21584775-084d-4b62-a479-adba4c48a280
identifier: gb-coh:4308099
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Akebia Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:4308099`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/21584775-084d-4b62-a479-adba4c48a280  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/21584775-084d-4b62-a479-adba4c48a280  

## Ownership & control

### Holdings / subsidiaries

- **KERYX BIOPHARMA UK LTD.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/29615c53-2800-534b-bd77-1d98c3e2a47a

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Akebia Therapeutics, Inc.** — https://whiteintel.dev/entity/21584775-084d-4b62-a479-adba4c48a280 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Akebia Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/21584775-084d-4b62-a479-adba4c48a280 · Structured JSON: https://whiteintel.dev/api/public/dossier/21584775-084d-4b62-a479-adba4c48a280._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._